Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: A case report

Clinics

Volumn 64, Issue 1, 2009, Pages 71-74

  Faria, Luciana C ^a   Resende, Clarissa C ^a   Couto, Cláudia A ^a,b   Couto, Osvaldo F M ^a   Fonseca, Lúcia P C ^a   Ferrari, Teresa Cristina A ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Uveitis Section   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; BILIRUBIN; BIOLOGICAL MARKER; COTRIMOXAZOLE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHOLESTASIS; FEMALE; HUMAN; LETTER; TIME;

ADULT; ALKALINE PHOSPHATASE; ANTI-INFECTIVE AGENTS; BILIRUBIN; BIOLOGICAL MARKERS; CHOLESTASIS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 58849104977     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000100014     Document Type: Letter

References (15)

1. Berg PA, Daniel PT. Co-trimoxazole-induced hepatic injury - an analysis of cases with hypersensitivity-like reactions. Infection. 1987;15 Suppl 5:S259-S264.
2. Zaman F, Ye G, Abreo KD, Latif S, Zibari GB. Successful orthotopic liver transplantation after trimethoprim-sulfamethoxazole associated fulminant liver failure. Clin Transplant. 2003;17:461-4.
3. Thies PW, Dull WL. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis: inadvertent rechallenge. Arch Intern Med. 1984;144:1691-2.
4. Kouklakis G, Mpoumponaris A, Zezos P, Moschos J, Koulaouzidis A, Nakos A, et al. Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole. Ann Hepatol. 2007;6:63-5.
5. Abi-Mansur P, Ardiaca MC, Allam C, Shamma'A M. Trimethoprim- sulfamethoxazole-induced cholestasis. Am J Gastroenterol. 1981;76:356-9.
6. Kowdley KV, Keeffe EB, Fawaz KA. Prolonged cholestasis due to trimethoprim sulfamethoxazole. Gastroenterology. 1992;102:2148-50.
7. Muñoz SJ, Martinez-Hernandez A, Maddrey WC. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim- sulfamethoxazole. Hepatology. 1990;12:342-7.
8. Ogilvie AL, Toghill PJ. Cholestatic jaundice due to co-trimoxazole. Postgrad Med J.1980; 56: 202-04.
9. Nair SS, Kaplan JM, Levine LH, Geraci K. Trimethoprim-sulfamethoxazole- induced intrahepatic cholestasis. Ann Intern Med. 1980;92:511-2.
10. Steinbrecher UP, Mishkin S. Sulfamethoxazole-induced hepatic injury. Dig Dis Sci. 1981;26:756-9.
11. Coto H, Mcgowan WR, Pierce EH Jr, Thomas E. Intrahepatic cholestasis due to trimethoprim-sulfamethoxazole. South Med J. 1981;74:897-8.
12. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349:474-85.
13. Ruiz-Irastorza G, Montejo M, Ituarte J, Aguirre C. Colestasis prolongada tras dosis única de cotrimoxazol. Rev Clin Esp. 1996;196:87-8.
14. Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol. 1994;89:1230-4.
15. Yao F, Behling CA, Saab S, Li S, Hart M, Lyche KD. Trimethoprim- sulfamethoxazole-induced vanishing bile duct syndrome. Am J Gastroenterol. 1997;92:67-9.